R.V. Moerman

No picture available
E-mail:
r.v.mayorova umcg.nl

Research

Publications
  1. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjogren's syndrome

    Verstappen, G. M., Moerman, R., van Nimwegen, J. F., van Ginkel, M. S., Bijzet, J., Mossel, E., Vissink, A., Hazenberg, B. P. C., Arends, S., Kroese, F. G. M. & Bootsma, H., 1-Oct-2018, In : Rheumatology. 57, 10, p. 1812-1821 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Physical fatigue characterises patient experience of primary Sjogren's syndrome

    Arends, S., Meiners, P., Moerman, R. V., Kroese, F. G. M., Brouwer, L., Spijkervet, F. K. L., Vissink, A. & Bootsma, H., 2017, In : Clinical and Experimental Rheumatology. 35, 2, p. 255-261 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Detailed Analysis of the Articular Domain in Patients with Primary Sjogren Syndrome

    Moerman, R. V., Arends, S., Meiners, P. M., Vissink, A., Spijkervet, F. K. L., Kroese, F. G. M., Brouwer, E. & Bootsma, H., Mar-2017, In : The Journal of Rheumatology. 44, 3, p. 292-296 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Physical fatigue characterises patient experience of primary Sjögren's syndrome

    Arends, S., Meiners, P. M., Moerman, R. V., Kroese, F. G. M., Brouwer, E., Spijkervet, F. K. L., Vissink, A. & Bootsma, H., 15-Mar-2017, In : Clinical and Experimental Rheumatology. 35, 2, p. 255-261 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Safety of treatments for primary Sjogren's syndrome

    van Nimwegen, J. F., Moerman, R. V., Smitt, N. S., Brouwer, E., Bootsma, H. & Vissink, A., 2-Apr-2016, In : Expert Opinion on Drug Safety. 15, 4, p. 513-524 12 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (10) »

ID: 37820689